Head of Communications, Ketryx

$120-160k

+ Stock options possible; + Possible performance bonus

Expert level
Boston

More information about location

4-5 days a week in office (Kendall Square, MA)

Ketryx

Connected application lifecycle management software for the life sciences industry

Open for applications

Ketryx

Connected application lifecycle management software for the life sciences industry

21-100 employees

HealthcareB2BArtificial IntelligenceComplianceSaaSCyber SecurityAutomationMedTech

Open for applications

$120-160k

+ Stock options possible; + Possible performance bonus

Expert level
Boston

More information about location

4-5 days a week in office (Kendall Square, MA)

21-100 employees

HealthcareB2BArtificial IntelligenceComplianceSaaSCyber SecurityAutomationMedTech

Company mission

To make systems safe and reliable.

Company mission

To make systems safe and reliable.

Our take

With the rate of MedTech development, life-changing innovations can be slowed and even thwarted by complex FDA regulatory processes and compliance issues. Ketryx is a software company that helps MedTech solutions reach the market at a quicker pace, with its AI-powered platform that supports safe and compliant software development.

The company's Connected Lifecycle Management Platform uses artificial intelligence to remove the chances of human error in product development, allowing for rigorous and fast quality assurance through automation. It also helps companies manage the frequent software updates required to create MedTech products within an increasingly complex ecosystem.

With few competitors in the MedTech lifecycle management space, Ketryx is a step ahead with its several rounds of funding. The latest raise will be put into expanding access to its platform, with the hope that more and more MedTech software developers will want to outsource their safety and compliance management rather than create complex systems in-house.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Benefits

  • Flexible locations and working hours

Funding (last 2 of 3 rounds)

Dec 2023

$14m

SERIES A

Jun 2022

$2m

EARLY VC

Total funding: $18.1m

This company has top investors

Leadership

Erez Kaminski

(Founder & CEO)

Previously Strategic Planning and Operations Manager at Amgen, Technology Specialist at Wolfram, as well as a Researcher at Princeton Plasma Physics Laboratory.